Literature DB >> 15544930

Non-classical regulation of estrogen receptor-alpha by ICI182,780.

Michael M Wang1, Richard J Traystman, Patricia D Hurn, Tongyun Liu.   

Abstract

Estrogen receptor-alpha (ER alpha) regulates transcription through a number of molecular mechanisms. Two mechanisms by which ER alpha acts directly in the nucleus have emerged: (1) in classical ER alpha action, estrogen-bound receptor binds estrogen response elements (ERE) and regulates promoters by recruiting coactivators or corepressors to DNA; (2) non-classical action is not dependent on ER alpha binding to EREs; its mechanism is not as clearly defined as classical action. In many instances, non-classical action is mediated by tethering of ER alpha to other DNA-binding proteins, facilitating recruitment of coregulators to transcription regulatory sequences. In some cell types, non-classical stimulation can be enhanced by antagonists and repressed by agonists of ER alpha. Here, we show that non-classical action of ER alpha in 293 cells occurs in a wide range of enhancers and enhancer binding proteins. ER alpha stimulates AP-1 elements, cyclic AMP response elements (CRE), and serum response elements (SRE) in the presence of the antiestrogen ICI182,780. Further, in the presence of ICI182,780, ER alpha stimulates activation domains of Jun, ATF-2, Elk, and CRE-binding protein (CREB). Non-classical ER alpha regulation described here does not appear to be sensitive to point mutations which affect classical and tethered ER alpha action; moreover, in our experiments, non-classical action is uniquely sensitive to nuclear transport inhibition by leptomycin B. Because ICI182,780 appears to affect multiple and diverse transcriptional systems, our results are likely explained by ER alpha-dependent modulation of common components of the transcriptional machinery and may not be completely explained by tethering of ER alpha to specific transcription factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544930     DOI: 10.1016/j.jsbmb.2004.06.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

Review 1.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  p150/glued modifies nuclear estrogen receptor function.

Authors:  Soo Jung Lee; Christina Chae; Michael M Wang
Journal:  Mol Endocrinol       Date:  2009-02-19

3.  TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.

Authors:  Christina Bjerre; Lena Vinther; Kirstine C Belling; Sidse Ø Würtz; Rachita Yadav; Ulrik Lademann; Olga Rigina; Khoa Nguyen Do; Henrik J Ditzel; Anne E Lykkesfeldt; Jun Wang; Henrik Bjørn Nielsen; Nils Brünner; Ramneek Gupta; Anne-Sofie Schrohl; Jan Stenvang
Journal:  Tumour Biol       Date:  2013-07-24

Review 4.  Structural and Functional Diversity of Estrogen Receptor Ligands.

Authors:  Amjad Farooq
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

5.  Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.

Authors:  M C Abba; E Lacunza; M Butti; C M Aldaz
Journal:  Biomark Insights       Date:  2010-10-27

6.  Estrogen induces rapid translocation of estrogen receptor beta, but not estrogen receptor alpha, to the neuronal plasma membrane.

Authors:  L C Sheldahl; R A Shapiro; D N Bryant; I P Koerner; D M Dorsa
Journal:  Neuroscience       Date:  2008-02-29       Impact factor: 3.590

Review 7.  Membrane estradiol signaling in the brain.

Authors:  Paul Micevych; Reymundo Dominguez
Journal:  Front Neuroendocrinol       Date:  2009-05-04       Impact factor: 8.606

8.  Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells.

Authors:  Junfeng Shi; Yi Chen; Wenxing Chen; Cuiju Tang; Honghong Zhang; Yuetong Chen; Xiuwei Yang; Zhi Xu; Jingsun Wei; Jinfei Chen
Journal:  J Cell Mol Med       Date:  2018-09-04       Impact factor: 5.310

9.  Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.

Authors:  Amy L Strong; Jason F Ohlstein; Quan Jiang; Qiang Zhang; Shilong Zheng; Stephen M Boue; Steven Elliott; Jeffrey M Gimble; Matthew E Burow; Guangdi Wang; Bruce A Bunnell
Journal:  Stem Cell Res Ther       Date:  2014-08-28       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.